Ethyl Acetate → 6-bromo-2-(5-tert-butyl-2-methyl-2H-pyrazol-3-yl)-3H-imidazo[4,5-c]pyridine

HRID 1191259ノート

反応式

HRID 1191259 の反応式
[Br:1][C:2]1[CH:7]=[C:6]([NH:8][C:9]([C:11]2[N:12]([CH3:20])[N:13]=[C:14]([C:16]([CH3:19])([CH3:18])[CH3:17])[CH:15]=2)=O)[C:5]([N+:21]([O-])=O)=[CH:4][N:3]=1.CCOC(C)=O.C([O-])(O)=O.[Na+]>C(O)(=O)C.[Fe]>[Br:1][C:2]1[N:3]=[CH:4][C:5]2[NH:21][C:9]([C:11]3[N:12]([CH3:20])[N:13]=[C:14]([C:16]([CH3:19])([CH3:18])[CH3:17])[CH:15]=3)=[N:8][C:6]=2[CH:7]=1

参加物

6

反応条件

温度
110 °C

実験手順

A solution of 5-tert-butyl-2-methyl-2H-pyrazole-3-carboxylic acid (2-bromo-5-nitro-pyridin-4-yl)-amide (79.8 mg, 0.183 mmol, prepared as described in the previous step) in acetic acid (1 mL) was treated with Fe powder (102 mg, 1.82 mmol). The resulting mixture was stirred at 110° C. for 1 h, cooled to room temperature, and treated with EtOAc (10 mL) and saturated NaHCO3 (10 mL). The organic layer was separated, washed with saturated NaHCO3 (10 mL), H2O (10 mL), concentrated, and the resulting residue dried in vacuo to yield 6-bromo-2-(5-tert-butyl-2-methyl-2H-pyrazol-3-yl)-3H-imidazo[4,5-c]pyridine. 1H-NMR (400 MHz, CDCl3) δ: 10.0 (br s, 1H), 8.80 (br s, 1H), 7.60 (br s, 1H), 6.60 (m, 1H), 4.40 (s, 3H), 1.30 (s, 9H).

後処理

  1. temperaturecooled to room temperature
  2. customThe organic layer was separated
  3. washwashed with saturated NaHCO3 (10 mL), H2O (10 mL)
  4. concentrationconcentrated
  5. customthe resulting residue dried in vacuo

出典と根拠

ORDレコード
ord-4f607b7b68c741579b0488e7cecbf3d7
出典データセット
uspto-grants-2014_03
特許番号
US08680098B2

反応ノート

読み込み中…